Biosimilar granulocyte–colony‐stimulating factor for mobilization of autologous peripheral blood stem cells in pediatric hematology‐oncology patients

Publisher： John Wiley & Sons Inc

E-ISSN： 1537-2995|55|2|246-252

ISSN： 0041-1132

Source： TRANSFUSION, Vol.55, Iss.2, 2015-02, pp. : 246-252

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Plerixafor and granulocyte‐colony‐stimulating factor for mobilization of hematopoietic stem cells for autologous transplantation in Chinese patients with non−Hodgkin's lymphoma: a randomized Phase 3 study

By  

TRANSFUSION, Vol. 58, Iss. 1, 2018-01 ,pp. : 81-87

John Wiley & Sons Inc

Access to resources Recommend Favorite

Biosimilar granulocyte–colony‐stimulating factor for healthy donor stem cell mobilization: need we be afraid?

By  

TRANSFUSION, Vol. 55, Iss. 2, 2015-02 ,pp. : 430-439

John Wiley & Sons Inc

Access to resources Recommend Favorite

Kinetics of Granulocyte Colony-Stimulating Factor in the Human Milk of a Nursing Donor Receiving Treatment for Mobilization of the Peripheral Blood Stem Cells

By  

Acta Haematologica, Vol. 118, Iss. 3, 2007-10 ,pp. : 176-177

Karger

Access to resources Recommend Favorite

FDA Review Summary: Mozobil in Combination with Granulocyte Colony-Stimulating Factor to Mobilize Hematopoietic Stem Cells to the Peripheral Blood for Collection and Subsequent Autologous Transplantation

By  

Oncology, Vol. 78, Iss. 3-4, 2010-06 ,pp. : 282-288

Karger

Access to resources Recommend Favorite

Unstable angina in a peripheral blood stem and progenitor cell donor given granulocyte–colony‐stimulating factor

By  

TRANSFUSION, Vol. 39, Iss. 5, 1999-05 ,pp. : 542-543

John Wiley & Sons Inc

Access to resources Recommend Favorite